RxDoctor Payments Data

Tarita Thomas, MD

Radiation Oncology · Chicago, ILNPI 1659572014

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $5,088 of the $8,306 with a category attached, or 61.2%. Viewray Technologies Inc accounts for 62.8% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2022 at $5,215 and has fallen 96.0% since, to $208 in 2025.

$8,306in general payments, 2019–2025

Across 23 payments — averaging $361.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Viewray Technologies Inc$5K
  • Servier Pharmaceuticals LLC$2K
  • Elekta, Inc.$526
  • Novocure Inc.$305
  • Tactile Systems Technology Inc$145
  • AstraZeneca$112
  • plus $35 from 1 others

What the payments were for

  • Consulting fees$5,08861%
  • Travel & lodging$1,55319%
  • Food & beverage$1,66620%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$8,306 in reported general payments places this provider in the 85th percentile of 242 radiation oncology providers in Illinois.

See all radiation oncology providers in Illinois

Medicare billing

Part B allowed, 2024
$206,453
Medicare patients
183
Services billed
2,186

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other radiation oncology in Chicago

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →